Matthew Jones

Cost Recovery Programs with respect to the Pest Management Regulatory Agency for registered pest control products, the Health Products & Food Branch for hard surface disinfectants, sanitizers and food contact sanitizers and CEPA's New Substances Regulations. Food and Drug Regulations with respect to the pre-market authority for the sale of disinfectant products, sanitizers, food contact sanitizers and post-market reporting. Canadian Environmental Protection Act (CEPA) with respect to amendments (S5). Competition Act with respect to Environmental Claims Guidance, Made in Canada/Product of Canada Guidance. Canadian Environment Protection Act and its regulations for Volatile Organic Compounds in certain products and HFCs. Pest Control Products Act and regulations of domestic and institutional pest control products. Hazardous Products Act and Regulations regarding interpretation and technical amendments/guidance to the Workplace Hazardous Materials Information System. Chemicals Management Plan regarding the review of existing, and new substances, which may be used in consumer and commercial products. Cabinet Directive on Regulation regarding the expectations and requirements in the development, management and review of federal regulations. Controlled Drugs & Substances Regulation with regard to precursors Canada Consumer Product Safety Act, in respect of regulations for labelling, incident reporting and compliance of consumer products.

Implementation of Bill S-5 An Act to Amend the Canadian Environmental Protection Act Respecting proposed changes to the assessment and management of Chemicals and Products; the Right to a Healthy Environment; the protection of Vulnerable Populations; the creation of a 'Watch List' for chemical substances; and the protection of confidential business information. Environmental Policy in terms of providing input concerning chemical manufacturing operations and the substances produced and used by the industry Canadian Environmental Protection Act (CEPA) as it relates to Population and Children's Health in terms of providing input on substances used or produced by the chemical industry

Discussion re: joint government/industry work on chemical and plastics in Canadian supply chains + development of joint consultation process. Discussion on policies and programs related to chemicals management, including the safe use, handling, and oversight of substances within the chemical and plastics industries, and their connection to sustainability and Responsible Care® practices. General introduction to the chemistry and plastics industries and their role in Canada’s economy and sustainability objectives. Advocating for CIAC’s pre-budget recommendations to strengthen investment attraction, advance climate policy, and improve plastics sector competitiveness. Addressed the impacts of rail labour disruptions on supply chain efficiency and overall industry performance. Environment, Health, and Industry policies related to plastics, in terms of providing input on the development and implementation of the Federal Plastics Registry and Recycled Content Requirement. Engaging on Canada’s participation in the Intergovernmental Negotiating Committee (INC) process on a global treaty to address plastic pollution, including impacts on the marine environment. International Trade Issues associated with cross border trade between Canada and the USA. This includes negotiations with the USA on the implementation of the Canada, US, Mexico Agreement (CUSMA) and other trade agreements. Impact of US Tariffs on Canadian industry. Communicating with public office holders to promote the industry cluster in Sarnia-Lambton and its long term sustainability Accelerated Capital Cost Allowance Program: making it permanent or extending it to align with Canada’s ITCs for emissions reduction. Water policy in terms of providing input on the impact of chemical manufacturing operations and the substances used/produced by the industry Transportation of Dangerous Goods Act: providing input related to the Transportation Code contained in the chemical industry's Responsible Care® Ethic and the safe management of chemicals in transport Scientific Research and Experimental Development (SR&ED) Tax Credit: providing input on its applicability to research in the chemical industry Occupational Health and Safety Workplace Hazardous Material Information System (WHMIS) and Globally Harmonized System (GHS): input on the impact of the chemical industry within the context of the Responsible Care® Ethic Impact of Carbon Pricing or emission intensity criteria on industry. Environmental Policy: input on chemical manufacturing operations and the substances produced and used by the industry Energy Policy: greater federal/provincial alignment on energy policies and streamlined environmental assessments for energy projects. Economic and Fiscal Policy: input on federal financial and tax issues Competition Act: impact of federal policies on the competitiveness of the Canadian chemical and plastic industries; Bill C-59 and amendments to greenwashing provisions. Concerns regarding climate change policies: impact of carbon pricing and emissions criteria on the industry. Climate Change Policy: input on federal federal strategies and processes to address greenhouse gas emissions Clean Air Regulatory Framework and Comprehensive Air Management System: Impact on the chemical and plastic industries. Chemical Industry Statistics: Data related to the chemical and plastic industries. Canadian Environmental Protection Act (CEPA): Application to substances produced or used in the chemical and plastic industries. Canadian Environmental Assessment Act and Regulations: impact on assessments of projects in the chemical and plastic industries. Canada Transportation Act: provisions related to railways and impact on the Canadian chemical and the plastic industries. Bill S-5 An Act to Amend the Canadian Environmental Protection Act 1999, to make related amendments to the Food and Drugs Act and to repeal the Perfluorooctane Sulfonate Virtual Elimination Act (CEPA Modernization). Key areas: changes to the

Accelerated Capital Cost Allowance Program: making it permanent or extending it to align with Canada’s ITCs for emissions reduction. Water policy in terms of providing input on the impact of chemical manufacturing operations and the substances used/produced by the industry Transportation of Dangerous Goods Act: providing input related to the Transportation Code contained in the chemical industry's Responsible Care® Ethic and the safe management of chemicals in transport Scientific Research and Experimental Development (SR&ED) Tax Credit: providing input on its applicability to research in the chemical industry Occupational Health and Safety Workplace Hazardous Material Information System (WHMIS) and Globally Harmonized System (GHS): input on the impact of the chemical industry within the context of the Responsible Care® Ethic Impact of Carbon Pricing or emission intensity criteria on industry. Environmental Policy: input on chemical manufacturing operations and the substances produced and used by the industry Energy Policy: greater federal/provincial alignment on energy policies and streamlined environmental assessments for energy projects. Economic and Fiscal Policy: input on federal financial and tax issues Competition Act: impact of federal policies on the competitiveness of the Canadian chemical and plastic industries; Bill C-59 and amendments to greenwashing provisions. Concerns regarding climate change policies: impact of carbon pricing and emissions criteria on the industry. Climate Change Policy: input on federal federal strategies and processes to address greenhouse gas emissions Clean Air Regulatory Framework and Comprehensive Air Management System: Impact on the chemical and plastic industries. Chemical Industry Statistics: Data related to the chemical and plastic industries. Canadian Environmental Protection Act (CEPA): Application to substances produced or used in the chemical and plastic industries. Canadian Environmental Assessment Act and Regulations: impact on assessments of projects in the chemical and plastic industries. Canada Transportation Act: provisions related to railways and impact on the Canadian chemical and the plastic industries. Bill S-5 An Act to Amend the Canadian Environmental Protection Act 1999, to make related amendments to the Food and Drugs Act and to repeal the Perfluorooctane Sulfonate Virtual Elimination Act (CEPA Modernization). Key areas: changes to the assessment and management of Chemicals and Products; the Right to a Healthy Environment; the protection of Vulnerable Populations; the creation of a "Watch List" for chemical substances; and the protection of confidential business information. Amendments to the Canadian Environmental Protection Act to remove plastic manufactured items from the list of toxic substances in Schedule 1 – Bill C-380 International Trade Issues associated with cross border trade between Canada and the USA. This includes negotiations with the USA on the implementation of the Canada, US, Mexico Agreement (CUSMA) and other trade agreements including the Trans Pacific Partnership (TPP). World Trade Organization (WTO) and regional free trade negotiations and policies in terms of providing input on the impact of exports and imports in Canada. Marine Policy in terms of providing input on chemical emergency response plans Impact of Clean Fuel Standard (CFS) on industrial operations in Canada Federal government plan to set explicit targets for diverting plastic waste and eliminate the unnecessary use of single-use plastics in government operations Amendments to the Canadian Environmental Protection Act relating to the export of plastic waste – Bill S-234

HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investments in health and social-determinants-of-health related programs, including measures to address the opioid crisis, mental health and addictions, and the regulation of natural health products. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key s

BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES: Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian

INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to health care facilities for health care workers and patients. PERSONAL INFORMATION PROTECTION AND ELECTRONIC DOCUMENT ACT (PIPEDA) PRIVACY PROTECTION OF HEALTH INFORMATION AND THE REGULATORY REVIEW: Improvement to privacy legislation to protect the privacy of health information. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. NET ZERO: Advocate for sustainable health systems in Canada, including reaching net-zero emissions by 2050; advocate for the establishment of a national climate and health secretariat within the federal government to develop a pan-Canadian approach to addressing the impacts of climate change and health; and advocate for a targeted health infrastructure fund as part of the federal government’s long-term plan for public infrastructure. MEDICAL ASSISTANCE IN DYING: Advancing the medical profession’s perspectives on medical assistance in dying. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. INDIGENOUS HEALTH AND RECONCILIATION WITH INDIGENOUS PEOPLES: Implementation of the Calls to Action of the Truth and Reconciliation Commission, including addressing the ongoing structural inequities that marginalize Indigenous Peoples, advancing the inclusion of Indigenous Peoples in societal systems and sectors, including health systems, and committing to collaborative and respectful relationships with Indigenous patients and communities. The CMA is also advocating to increase trust between Ind

The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs Improve safeguards for Canadian health data Improve labour mobility so physicians can work across the country Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, and advocacy on discontinuing the requirement that employees present sick notes to their employers. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada, including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. THE ACQUISITION AND THE DOMESTIC SUPPLY OF PERSONAL PROTECTIVE EQUIPMENT FOR HEALTH CARE PROVIDERS: Ensuring the federal government take additional measures ensure adequate supply, proper distribution, and appropriate usage of personal protective equipment throughout health systems. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector including input on Bill C-27, and the means through which advancements can be foreseen and managed. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key stakeholders, including the public, physicians, patients/PWLE, policymakers, system leaders and others, in a dialogue on public-private healthcare. What we hear will inform CMA policy moving forward, and our recommendations for action at a national level. PHYSICIAN PARLIAMENTARIAN CAUCUS: advocate for the formation of a Physician Parliamentarian Caucus as a means of examining deficiencies in the health care system and proposing solutions. PHYSICAL, PSYCHOLOGICAL AND CULTURAL SAFETY: Advocate to address the challenges and opportunities for physical, psychological and cultural safety within Canada’s health system, including the implementation of a nation-wide anti-racism plan, the creation of a Canada Mental Health transfer, improving access to mental health services to physicians and their families, gender-affirming care, creating an emergency National Mental Health Support Services hotline for all health care providers, the creation of a National Physicians Day in Canada, ensuring safe and unimpeded access to

Efforts to modernize federal privacy legislation and regulate artificial intelligence. An Act respecting cyber security, amending the Telecommunications Act and making consequential amendments to other Acts and its application to the insurance industry (C-8) Issues relating to emergency preparedness, response and recovery including a National Recovery Strategy, and the creation of a National Emergency Management Agency Expansion of the trade credit insurance market in Canada Proposed public-private partnership with the insurance industry to better protect Canadians in the event of a major earthquake. Issues relating to flooding including the creation of a low-cost high-risk National Flood Insurance program in partnership with the P&C insurance industry. Other issues include flood mapping and infrastructure investment. Developing a national approach and vehicle safety standards for the deployment of connected and automated vehicles Implementation of the National Adaptation Strategy and other issues relating to climate adaptation and including modernization of DFAA, DMAF, and infrastructure investments. Changes to the Minimum Capital Test (MCT) and solvency regulations. Changes to the reinsurance framework. Changes to other guidelines (i.e. Guidelines B10, B13, B15; Guidelines E13, E21, E23, etc.). Implementation of the national auto theft strategy and other solutions to combat the theft of vehicles in (and illegal export of vehicles from) Canada. National Coordination of provincial stolen and wrecked vehicle programs. (Transport Canada), with regard to allowing the exchange of information in order to prevent the fraudulent "re-VINing" of vehicles. This refers to the practice of changing the Vehicle Information Number (VIN) on a stolen or wrecked vehicle, thus facilitating its fraudulent re-sale. Financial sector policy and regulatory changes pursuant to the implementation of the United States-Mexico-Canada Agreement (USMCA), formerly North American Free Trade Agreement.

Legislation, regulation, policies, and programs concerning the federal government’s future pandemic preparedness and personal protective equipment supply chain management. Activities around amending the Hazardous Product Regulations (HPR), VOC, and Pest Control acts. Confidential Business Information to harmonize with other jurisdictions. The creation of tax reform to support Canadian manufacturers Technology improvements and processes for Defence procurement programs including soldier safety, Shipbuilding, Aerospace technology and Army Equipment. Addressing proposals surrounding tariffs and trade policy Recommendations for policies addressing labour shortages in skilled trades,supporting STEM education and training, and worker safety S-5 An Act to Amend the Canadian Environmental Protection Act and other Acts. Respecting proposed changes to the assessment and management of Chemicals and Products; the creation of a 'Watch List' for chemical substances; and the protection of confidential business information. National Shipbuilding Strategy Programs with respect to technology around advanced materials Legislation and regulation with respect to the creation of a plastics registry, plastic labelling or recycled content for plastic products. GHG reduction measures, in respect to the Clean Fuel Standard, Carbon Pricing, Out-Based Pricing System and other GHG reduction policies and regulations. Chemicals Management Plan under Environmental Protection Act 1999 regarding the review of substances, which may be used in consumer products. Canadian Chemical Management Plan under Environmental Protection Act 1999, with respect to schedule 1 of the act. Interact with Health and Environment and Climate Change Canada for impacted reviewed Chemicals as appropriate. Canada's Implementation of the Globally Harmonized System of Classifications and Labelling of Chemicals mainly as it relates to regulatory and implementation alignment with the US Budget recommendations in respect to use of tax relief and fiscal incentives to drive meaningful innovation and promote commercialization Budget recommendations in respect of creating a federal innovation agenda with tools aimed at enhancing Canadian industry performance Budget recommendations in respect of developing a Climate Change policy in a manner promoting innovation and economic development Budget recommendations in respect of reducing impediments to trade and flow of people Better alignment of regulatory requirements between Canada and US to streamline regulatory approvals and avoid duplication.

Advising on the climate, environmental, and economic risks of new bitumen pipelines and related fossil fuel industry expansion, and seeking to mitigate harms. Seeking to stop proposal changes to Impact Assessment Act, Fisheries Act and Species at Risk Act that the federal government released a spring 2026 discussion paper concerning proposed changes to the IAA, Fisheries Act and SARA that would significantly weaken protection of environment and human health Seeking that the federal government deny changes to the Tripartite Agreement, and therefore not enable a process toward expanding the Toronto Island Airport to accommodate jets. Supporting the federal government's plans and financial support for decarbonizing steel production in Canada. Seeking Cabinet Emergency Order to protect the critical habitat of piping plover at Wasaga Beach Supporting the federal government in its negotiation of a strong international treaty on plastic pollution. Supporting federal action establishing a Federal Plastics Registry requiring producers to report annually on the quantity and types of plastic they place on the Canadian market, how it moves through the economy, and how it is managed at its end-of-life. Advising on the climate impacts of existing or proposed LNG projects, as well as the global business environment for LNG, and seeking to mitigate harms. Advising on the environmental impacts of projects enabled by Bill C-5 and seeking to mitigate harms. Environmental and industrial strategy approaches to reducing waste and material inputs Seeking a strengthening of the Output-based pricing system intended to make polluters pay Supporting the implementation, under the Canadian Environmental Protection Act, of Clean Electricity Regulations to mitigate climate change and build a low carbon future. Supporting stronger regulations under the Fisheries Act on Oil Sands Mining Effluent Release. Supporting investment in systems for reuse and refill as an alternative to single-use packaging. Supporting a Climate-Aligned Finance Act, that would include enforcing science-based targets and holding financial institutions accountable to them. Federal Budget - providing resources for environmental initiatives, including climate change, public transit, renewable energy, climate finance accountability, investment in water and wastewater infrastructure, pollution abatement and enforcement, economic transition, sustainable jobs, aligning federal spending with climate objectives and restricting resources for fossil fuels. Rouge National Urban Park expansion involving the former Pickering Airport lands. Supporting the strengthening of current and future federal government emission reduction targets. Ensure a green investments Taxonomy does not include fossil fuels. Advancing climate transition plans across the economy, requiring federally regulated financial institutions and large companies to develop and implement plans that align their business with the goals of the Paris Agreement. Supporting federal action to protect communities and ecosystems from local impacts in the oil sands, including from seeping oil sands process water. Supporting the establishment, under the Canada Consumer Product Safety Act (CCPSA), of regulations requiring disclosure, and prohibitions, restrictions, or container requirements for certain human health hazards of concern (HHHOCs) in consumer chemical products. Supporting the establishment of the Canada Public Transit Fund and negotiated infrastructure funding agreements with provinces, territories, and cities, where the federal government would establish land-use standards near federally funded transit stations, establish zero-emission bus procurement requirements and expand operations funding to increase transit service levels. Supporting the establishment, under the Canadian Environmental Protection Act, of regulations to address plastic pollution. Supporting the establishment, under the Canadian Environmental Protection Act, of reg

Infrastructure - Expand opportunities for long-term investors to support infrastructure investment, including opportunities to support investment in housing. Pensions & savings plans – Engage with public office holders regarding enhancing retirement and savings security for Canadians through retirement planning, public and registered savings plans, annuities, etc. Prescription drugs - Seeking to raise awareness about prescription drug & workplace benefit coverage. Group benefits & paramedical health care – Engage with public office holders regarding health care programs and policy that may impact group benefit plans. Climate/Environment – Engagements related to the impacts of extreme weather on the health and wellness of Canadians and expanding opportunities to meet our decarbonization commitments. International relations & trade – Engage with public office holders regarding international relations as it relates to Canada’s insurance industry. This includes how best to maximize the benefits of Canada’s trade relations for the industry and broader economy. Insurance and health regulation and legislation - Engage with public office holders regarding Canada’s financial services and health care sectors, in relation to the insurance industry. This may include the industry’s governing legislation and regulations, taxation policy, administration, and related issues, guidelines & rules. Cyber security, data, and privacy – Engage with public office holders on how to ensure the safety and integrity of Canada’s insurance industry’s data and technology systems. This may include engagement on privacy legislation, policy, and technological innovation in the insurance industry.

Work with government to promote and support Canada’s digital economy, including ensuring the availability of a high-skilled tech workforce. Work with government to facilitate the process of selling goods and services online, and delivering them to consumers.

Démarches réalisées auprès des décideurs publics pour présenter l’Association Pour la Santé Publique du Québec (ASPQ) et son expertise en santé durable et pour les sensibiliser aux solutions possibles afin que les réseaux de santé du Canada se dotent d’objectifs concrets en matière de carboneutralité.

Finance: Government transformation and efficiency, tax shelter and innovation programs Non-tariff trade barriers associated non-science based regulations in the EU, Mexico and China science-based approach to pesticide policy Technology platforms that enable climate-smart practices and reducing the environmental footprint Patent legislation with respect to Intellectual Property and Innovation regarding the Patent Act. Growing Forward Agriculture and Agri-Food Canada program with respect to Innovation, Science and Technology Biotechnology bio-Products with respect to plants with novel traits and bio-products.